Elif Kadife

163 Studley Road
Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial.

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial.

Journal: EClinicalMedicine

Published: August 06, 2025

Investigating the Impact of Maternal Obesity on Disease Severity in a Mouse Model of Preeclampsia.

Investigating the Impact of Maternal Obesity on Disease Severity in a Mouse Model of Preeclampsia.

Journal: Nutrients

Published: April 01, 2025

Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia.

Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia.

Journal: Reproductive biology and endocrinology : RB&E

Published: May 25, 2023

Acute exercise induces distinct quantitative and phenotypical T cell profiles in men with prostate cancer.

Acute exercise induces distinct quantitative and phenotypical T cell profiles in men with prostate cancer.

Journal: Frontiers in sports and active living

Published: February 24, 2023

SLC38A4 Amino Acid Transporter Expression Is Significantly Lower in Early Preterm Intrauterine Growth Restriction Complicated Placentas.

SLC38A4 Amino Acid Transporter Expression Is Significantly Lower in Early Preterm Intrauterine Growth Restriction Complicated Placentas.

Journal: International journal of molecular sciences

Published: November 21, 2022

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

Journal: Cancer cell international

Published: September 13, 2022

Novel genes associated with a placental phenotype in knockout mice also respond to cellular stressors in primary human trophoblasts.

Novel genes associated with a placental phenotype in knockout mice also respond to cellular stressors in primary human trophoblasts.

Journal: Placenta

Published: August 18, 2022

Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model.

Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model.

Journal: Placenta

Published: August 01, 2022

Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia.

Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia.

Journal: International journal of molecular sciences

Published: July 05, 2022

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.

Journal: Journal of translational medicine

Published: June 20, 2022

The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health.

The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health.

Journal: Life science alliance

Published: May 04, 2022

Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro.

Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro.

Journal: PloS one

Published: February 01, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026